Les Laboratoires Servier SAS, of Suresnes, France, and Yposkesi, a contract development and manufacturing firm for gene therapy viral vector manufacturing, said they signed a service agreement for Yposkesi to develop and GMP manufacture lentiviral vectors to support allogenic CAR T-cell technology development. Financial terms were not disclosed.